DE69805033T2 - Tetrazolderivate als LTD4 und H1 Antagonisten - Google Patents

Tetrazolderivate als LTD4 und H1 Antagonisten

Info

Publication number
DE69805033T2
DE69805033T2 DE69805033T DE69805033T DE69805033T2 DE 69805033 T2 DE69805033 T2 DE 69805033T2 DE 69805033 T DE69805033 T DE 69805033T DE 69805033 T DE69805033 T DE 69805033T DE 69805033 T2 DE69805033 T2 DE 69805033T2
Authority
DE
Germany
Prior art keywords
group
substituted
unsubstituted
hydrogen atom
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69805033T
Other languages
English (en)
Other versions
DE69805033D1 (de
Inventor
Hendrik Timmerman
Mingqiang Zang
Kazuhiro Onogi
Takeo Deushi
Masahiro Tamura
Tsutomu Tohma
Yasushi Wada
Jiro Matsumoto
Toru Kanke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of DE69805033D1 publication Critical patent/DE69805033D1/de
Publication of DE69805033T2 publication Critical patent/DE69805033T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Die Bonding (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DE69805033T 1997-09-26 1998-09-23 Tetrazolderivate als LTD4 und H1 Antagonisten Expired - Lifetime DE69805033T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26235697 1997-09-26

Publications (2)

Publication Number Publication Date
DE69805033D1 DE69805033D1 (de) 2002-05-29
DE69805033T2 true DE69805033T2 (de) 2002-11-14

Family

ID=17374614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805033T Expired - Lifetime DE69805033T2 (de) 1997-09-26 1998-09-23 Tetrazolderivate als LTD4 und H1 Antagonisten

Country Status (6)

Country Link
US (2) US6121286A (de)
EP (1) EP0905133B1 (de)
KR (1) KR100547506B1 (de)
AT (1) ATE216698T1 (de)
DE (1) DE69805033T2 (de)
ES (1) ES2176877T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231992T3 (es) * 1997-07-07 2005-05-16 Kowa Co., Ltd. Derivados de diamina y composiciones farmaceuticas que los contienen.
KR100882544B1 (ko) * 1999-05-24 2009-02-12 미쓰비시 타나베 파마 코퍼레이션 페녹시프로필아민 화합물
WO2003000685A1 (en) * 2001-06-20 2003-01-03 Takeda Chemical Industries, Ltd. 5-membered heterocycle derivatives
EP1424101A3 (de) * 2002-11-29 2004-08-18 NOZAKI, Masako Verwendung eines Leukotrien- C4/ D4 -rezeptorantagonisten zur Herstellung eines Medikamentes zur Behandlung oder Vorbeugung von Gehirnentzündung und -sepsis
US7148248B2 (en) 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis
DE602005023797D1 (de) 2004-07-14 2010-11-04 Inflammation Res Ct Co Ltd Verfahren zur Hemmung von Tumormetastasierung
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
US8507385B2 (en) * 2008-05-05 2013-08-13 Shanghai Lexvu Opto Microelectronics Technology Co., Ltd. Method for processing a thin film micro device on a substrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
US5756518A (en) * 1996-04-02 1998-05-26 Kowa Co., Ltd. Phenylene derivatives
ES2231992T3 (es) * 1997-07-07 2005-05-16 Kowa Co., Ltd. Derivados de diamina y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
KR19990030070A (ko) 1999-04-26
EP0905133A1 (de) 1999-03-31
ATE216698T1 (de) 2002-05-15
DE69805033D1 (de) 2002-05-29
ES2176877T3 (es) 2002-12-01
US6117886A (en) 2000-09-12
US6121286A (en) 2000-09-19
KR100547506B1 (ko) 2006-06-22
EP0905133B1 (de) 2002-04-24

Similar Documents

Publication Publication Date Title
ES2149186T3 (es) Derivados de dihidrochalcona hipoglicemicos.
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
IL174664A0 (en) Optically active amino alcohol derivatives and processes for the preparation thereof
DE3871916T2 (de) Thiazolidindione als hypoglykaemische und antiatherosklerotische mittel.
IL114875A (en) Quinolone or naphthylidone-carboxylic acid derivatives or their salts and pharmaceutical compositions containing them
DE69111816T2 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
DE69805033D1 (de) Tetrazolderivate als LTD4 und H1 Antagonisten
PT1157998E (pt) Compostos heterociclicos seus intermediarios e inibidores da elastase
DK0882728T3 (da) 1-methylcarbapenemderivater
DE60022986D1 (de) Pyridazin-3-on-derivate und sie enthaltende Arzneimittel
EP0312353A3 (en) Zearalanol derivatives with anabolic activity
DE69226931T2 (de) Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
DE69315363D1 (de) Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel
HU9602534D0 (en) Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
DE69803151D1 (de) Piperidinderivate als LTD4 und H1 Antagonisten
EP1201664A4 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
DE69706012D1 (de) N-Acylpiperazinderivat, antibakterielle und gegen Geschwüre wirksame Medikamente
DE60009301D1 (en) Benzimidazolverbindungen
DE60203029D1 (de) Benzopyran Derivate und diese enthaltende Antiallergisches Mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition